Rallybio Corp (RLYB) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution
This article provides a revenue breakdown for Rallybio Corp (RLYB), focusing on business segments, regional revenue, and profit contribution. It notes that relevant data for FY2025 and FY2024 has not yet been disclosed by the company, though it does show a United States revenue of $858.00K with 0.00% proportion. The article indicates that more detailed information is pending release from Rallybio Corp.
Radiant Logistics Inc (RLGT) Dividends & Stock Splits: Historical Payouts and Event Timeline
This article provides an overview of Radiant Logistics Inc (RLGT) focusing on its dividend and stock split history. It states that the company has distributed a total of $0.00 USD in dividends over the past five years and reports no data for historical stock splits. The current stock price and market capitalization are also listed.
Radiant Logistics Inc (RLGT) Shareholder Structure: Major Shareholders & Institutional Holdings
The article provides a detailed breakdown of Radiant Logistics Inc's (RLGT) shareholder structure, listing major individual and institutional holders and their respective proportions. It also categorizes shareholders by type and presents historical institutional shareholding data and recent shareholder activity. The information is current as of various dates in 2025 and 2026.
Delta Air Lines' New Long-Haul International Route Is Celebrated After Multiple Domestic U.S. Flight Cuts
Delta Air Lines has reinstated its Los Angeles-Hong Kong route after an eight-year hiatus, celebrating its return as a major Pacific comeback. This celebration is, however, overshadowed by recent domestic flight cuts within the U.S. and to popular vacation spots due to surging fuel costs linked to the U.S.-Iran conflict. These adjustments highlight Delta's efforts to balance strategic international expansion with cost management amid challenging operational conditions.
Meta (META) director Nancy Killefer granted 612 RSUs vesting in 2027
Meta Platforms, Inc. director Nancy Killefer received a grant of 612 Restricted Stock Units (RSUs) of Class A Common Stock. These RSUs are scheduled to vest 100% on May 15, 2027, with specific conditions related to board service and the 2027 annual shareholder meeting. This transaction was a compensation-related award and not a market purchase or sale of stock.
Bristol Myers Squibb (BMY) Unveils Myeloma Trial Win And New Gulf Leadership
Bristol Myers Squibb (BMY) announced positive Phase III trial results for a multiple myeloma treatment and encouraging early data for a new CAR T-cell therapy, bolstering its hematology pipeline. The company also appointed a new General Manager for the Gulf region, signaling a strategic focus on expanding its presence in developing healthcare markets. These developments aim to help BMY offset potential revenue losses from upcoming patent expirations and enhance its long-term financial stability.
Apple Will Raise Prices Due To Soaring Memory Costs, CEO Tim Cook Says - Apple (NASDAQ:AAPL), Amazon.com
Apple CEO Tim Cook has announced that the company will raise prices on its products due to soaring memory costs, calling the situation a "100-year flood" in the electronics supply chain. The price increases are a direct result of a dramatic reallocation of DRAM and NAND supply towards AI infrastructure, causing memory and storage chip prices to quadruple. Cook did not specify which devices would be affected or when the price changes would take effect.
DaVita Insiders Sold Shares Worth Over $17M
DaVita (DVA) insiders, including CEO Javier Rodriguez and Chief Legal & Public Affairs Officer Kathleen Alyce Waters, recently sold shares totaling over $17 million. Rodriguez sold shares worth $14,532,108 in two transactions, while Waters sold shares worth $3,210,376 through two transactions, partly under a Rule 10b5-1 trading plan. These sales were reported via SEC Form 4 filings.
RAPT Therapeutics Inc (RAPT) Valuation: PE, PB & Fair Value Analysis
This article provides a valuation analysis of RAPT Therapeutics Inc (RAPT), indicating its current valuation score is 6.76 within the Biotechnology & Medical Research industry. The company's P/E ratio is -4.99, which is significantly below its recent high and above its recent low. Key valuation metrics such as P/B, P/S, and P/CF are not yet disclosed by the company.
5 Most Promising Metaverse Stocks to Buy Now
This article identifies five promising metaverse stocks, focusing on companies with significant potential in this emerging digital space. It highlights Take-Two Interactive Software, Inc. (NASDAQ: TTWO) and discusses its future projects, particularly Grand Theft Auto VI, and its expected impact on fiscal year 2027 bookings. The piece uses hedge fund holder data and stock upside potential as key metrics for evaluating these investment opportunities.



